Diagnostic Challenges in Celiac Disease and the Role of the Tissue Transglutaminase–Neo-Epitope

@article{Matthias2010DiagnosticCI,
  title={Diagnostic Challenges in Celiac Disease and the Role of the Tissue Transglutaminase–Neo-Epitope},
  author={Torsten Matthias and Sascha Pfeiffer and Carlo Selmi and M. Eric Gershwin},
  journal={Clinical Reviews in Allergy \& Immunology},
  year={2010},
  volume={38},
  pages={298-301}
}
The diagnosis of celiac disease (CD) remains a clinical challenge based on the incomplete specificity and sensitivity rates of current non-invasive tests. Furthermore, histological assessments fail to identify all overt cases and, in particular, do not manifest pathognomonic alterations in silent cases. Accordingly, the majority of CD cases are diagnosed with great delay. Recent research into the pathogenesis of CD, allowed us to identify a neo-antigen that appears to be the most promising… Expand
Serologic Diagnosis of Celiac Disease: New Biomarkers.
TLDR
A new generation of anti-neo-epitope tTg check (IgG + IgA) has become available, highly sensitive and specific, covers IgA-deficient patients with CD, reflects intestinal damage, and has predictive potential in the diagnosis of CD. Expand
Assessment of a Test for the Screening and Diagnosis of Celiac Disease
TLDR
This study investigates the performance of an ELISA that uses the purified cross‐linked complex of tissue transglutaminase and gliadin, referred as the “neoepitope” (AESKULISA® tTG New Generation), as antigen. Expand
Novel trends in celiac disease
TLDR
These celiac neo-epitopes are comprised of a complex of gliadin peptides crosslinked with transglutaminase (tTg) and are an early diagnostic marker for CD which occurs up to 6 months earlier than classical markers known to miss a certain amount of CD patients. Expand
Serological Diagnosis of Celiac Disease –Moving Beyond the Tip of the Iceberg
TLDR
At present, there is insufficient information to demonstrate that screening general populations definitely results in clinical benefit, however, asymptomatic individuals in high-prevalence groups should be screened. Expand
Overview of biomarkers for diagnosis and monitoring of celiac disease.
  • I. Brusca
  • Medicine
  • Advances in clinical chemistry
  • 2015
Among the adverse reactions caused by wheat, celiac disease (CD) is the longest studied and best-known pathology. The more recently defined non-celiac gluten sensitivity (NCGS) presents with symptomsExpand
Cutting-Edge Issues in Celiac Disease and in Gluten Intolerance
TLDR
Some relevant aspects related to the laboratory diagnosis of CD and, more extensively, of gluten intolerance are considered, such as the best combination of tests for early and accurate diagnosis, the diagnostic role of new tests for detecting antibodies against neoepitopes produced by the transglutaminase–gliadin complex, the forms of non-celiac gluten intolerance (gluten sensitivity), and the use and significance of measuring cytokines in CD. Expand
A new algorithm for the diagnosis of celiac disease
TLDR
The newly proposed three-assay algorithm for celiac detection is very reliable in both children and adults and may be suitable for disease monitoring. Expand
Serological Markers and/or Intestinal Biopsies in the Case-finding of Celiac Disease
TLDR
Until recent observations are implemented in the future guidelines, small bowel histology should remain the gold standard for case-finding in CD. Expand
Digesting all the options: Laboratory testing for celiac disease
TLDR
The analytical methodology, strengths, weaknesses, diagnostic performance and clinical utility of the various laboratory tests for celiac disease are reviewed. Expand
A Novel Algorithm for the Diagnosis of Celiac Disease and a Comprehensive Review of Celiac Disease Diagnostics
TLDR
Using a combination of a sensitive assay together with specific assays improved celiac disease detection rates, with an acceptable number of false positive results, which needs to be confirmed prospectively in both children and adults. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 31 REFERENCES
The pathogenesis of coeliac disease.
TLDR
An improved understanding of the immune response to gluten is likely to lead to the development of novel strategies for the treatment of coeliac disease. Expand
Diagnostic accuracy of coeliac serological tests: a prospective study
TLDR
It is suggested that transglutaminase screening (using the IgA±IgG isotype) is a sensitive and specific alternative to endomysial antibody testing in the serological assessment of CD. Expand
Current concepts of celiac disease pathogenesis.
Our knowledge of celiac disease pathogenesis has recently made rapid progress. The disorder is now considered the result of a complex interplay of intrinsic (genetic) and variable extrinsicExpand
IgA anti-tissue transglutaminase: setting the stage for coeliac disease screening
TLDR
A validated and standardized enzyme-linked immunosorbent assay for serum IgA autoantibodies to tissue transglutaminase is a powerful non-invasive test for coeliac disease that promises a sensitivity and specificity close to 100%. Expand
Pathomechanisms in Celiac Disease
TLDR
Modification of gluten peptides by tTG can enhance their binding to HLA-DQ2 or -DQ8 and potentiate T cell stimulation, and tTG-catalyzed cross-linking and consequent haptenization of gluten with extracellular matrix proteins allows for storage and extended availability of gluten in the mucosa. Expand
Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods
TLDR
Multiplex immunoassay (MIA) measures multiple antibodies simultaneously providing a complete antibody phenotype with reduced turnaround time and cost. Expand
Extraintestinal manifestations of celiac disease
TLDR
Overall, autoimmune diseases occur more frequently in those with celiac disease than in the general population, although its effect on some of the extraintestinal manifestations remains to be determined. Expand
Coeliac Disease Gliadin is a Good Substrate of Several Transglutaminases: Possible Implication in the Pathogenesis of Coeliac Disease
TLDR
Gliadin is a good substrate for endogenous, microbial and plant transglutaminases, and an interesting alternative is that gliadins are deamidated by microbial or food transglUTaminases in the intestinal lumen. Expand
Coeliac disease
TLDR
Study of the mechanisms of the immune response in coeliac disease could provide insight into the mechanism of inflammatory and autoimmune responses and lead to innovations in treatment. Expand
Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa
TLDR
It is demonstrated that gliadin was directly bound to tTG in duodenal mucosa of coeliacs and controls, and the ability of circulating tTG‐autoantibodies to recognize and immunoprecipitate the t TG‐gliadin complexes is demonstrated. Expand
...
1
2
3
4
...